Daniel T. Milton

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Christopher G. Azzoli, Sherman Baker, Sarah Temin et al. · Journal of Clinical Oncology · 2009 · 912 citations · Full text

Tumor Microenvironment, Molecular Markers, Medicine +15

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (<i>EGFR</i>) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

Vicki L. Keedy, Sarah Temin, Mark R. Somerfield et al. · Journal of Clinical Oncology · 2011 · 479 citations

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Christopher G. Azzoli, Sarah Temin, Timothy Aliff et al. · Journal of Clinical Oncology · 2011 · 287 citations

Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus

Gregory J. Riely, Mark G. Kris, Binsheng Zhao et al. · Clinical Cancer Research · 2007 · 284 citations · Full text

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

Antonio Omuro, Mark G. Kris, Vincent A. Miller et al. · Cancer · 2005 · 229 citations